The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the most accurate at-home COVID-19 test* in the U.S., today announced that its ...

Consult virtually and on-demand with a healthcare professional about their test result; Obtain an e-prescription - if medically indicated - for a medication to treat the virus; and Get the medication ...

Two years after its cartridge-based diagnostic became the first COVID-19 test given emergency use authorization by the FDA for non-prescription, at-home use, Cue Health has now scored the agency’s ...

Every American traveling abroad needs to take an antigen test to return to the United States. But the start of the trip is often even more cumbersome, as many other countries (nearly every one I have ...

SAN DIEGO--(BUSINESS WIRE)-- Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

Scaling is difficult for any company. But when your business is primed for Covid-19, growth can be as viral as the disease. That’s the case for Cue Health, a San Diego-based health care technology ...

After racking up hundreds of millions in venture capital throughout the pandemic to support its COVID-19 test-making business, Cue Health will look to make its break into the public market with an IPO ...

When COVID-19 hit in March 2020, testing for the coronavirus was an absolute disaster. From manufacturing mistakes to botched rollouts to bad communication, it was incredibly difficult to track down a ...